Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENGN | AZN | AMGN | GILD | BMY |
| Company | Engene Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 7.24 | 202.64 | 347.46 | 140.12 | 58.70 |
| High | 7.25 | 205.98 | 356.55 | 142.27 | 59.54 |
| Low | 7.07 | 201.97 | 346.42 | 139.96 | 58.54 |
| Latest | 7.24 | 205.89 | 356.17 | 142.12 | 59.29 |
| Change | -0.07 | +1.62 | +6.36 | +0.58 | +0.09 |
| % Change | -0.96% | +0.79% | +1.82% | +0.41% | +0.15% |
| Volume | 49,413 | 505,663 | 1,124,768 | 1,184,187 | 1,951,198 |
| 20-Day Average Volume | 347,820 | 1,856,758 | 2,637,029 | 5,878,520 | 13,233,027 |
| Previous Close | 7.31 | 204.27 | 349.81 | 141.54 | 59.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.03 | 193.21 | 352.75 | 140.12 | 59.04 |
| 20-Day Raw Stochastic | 60.43% | 94.91% | 52.22% | 56.18% | 47.36% |
| 20-Day Relative Strength | 43.72 | 60.82 | 49.88 | 51.43 | 50.54 |
| Weighted Alpha | +26.89 | +54.60 | +25.82 | +37.10 | +23.31 |
| Today's Opinion | 16% Sell | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Previous Opinion | Hold | 88% Buy | 40% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 24% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.21% since 04/01/26 | +2.37% since 04/01/26 | +0.75% since 04/01/26 | +1.17% since 04/01/26 | -4.12% since 04/01/26 |
| Low | 6.53 on 04/02/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 7.72 on 04/08/26 | 206.73 on 04/08/26 | 356.01 on 04/09/26 | 141.94 on 04/09/26 | 60.58 on 04/02/26 |
| 1-Month | |||||
| %Chg | +1.84% since 03/09/26 | +5.41% since 03/09/26 | -5.59% since 03/09/26 | -3.20% since 03/09/26 | -2.38% since 03/09/26 |
| Low | 6.05 on 03/30/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 7.92 on 03/17/26 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -18.50% since 01/09/26 | +8.55% since 01/09/26 | +9.14% since 01/09/26 | +17.21% since 01/09/26 | +5.95% since 01/09/26 |
| Low | 6.05 on 03/30/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 12.25 on 01/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -19.24% since 10/09/25 | +20.82% since 10/09/25 | +20.47% since 10/09/25 | +21.59% since 10/09/25 | +32.46% since 10/09/25 |
| Low | 5.72 on 11/07/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 12.25 on 01/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 489,660 | 316,803,968 | 188,571,376 | 175,682,560 | 120,870,712 |
| Shares Outstanding, K | 66,985 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -117,300,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -29,750,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -0.06 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 03/09/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 06/11/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | 12/24/14 | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.92 | 15.56 | 17.03 | 9.38 |